BackElevation Oncology Overview

Elevation Oncology Current Cash

Elevation Oncology's current cash is $60M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$60.49M
↓ 33.25% YoYΔ $-30.14M vs prior year quarter

Peer trimmed avg / median

Loading

Elevation Oncology Current Cash History

Loading

Elevation Oncology vs. peers: Current Cash Comparison

Loading

Elevation Oncology Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Elevation Oncology (ELEV) FAQ

As of the most recent data (March 2025), ELEV shows a current cash of $60M. That compares with $91M in the prior-year period — down 33.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ELEV's current cash is now $60M (was $91M) — a 33.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Elevation Oncology is outperforming or lagging.

Tracking ELEV's current cash over time shows whether Elevation Oncology is scaling, shrinking, or reshaping that part of the business. The current reading is $60M That compares with $91M in the prior-year period — down 33.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Elevation Oncology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $60M) with ownership activity and broader fundamentals.

Elevation Oncology's current cash is $60M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.